CAMPBELL NEWMAN ASSET MANAGEMENT INC

Position in HALO — Halozyme Therapeutics, Inc.

CIK 874791 MILWAUKEE, WI

Position in HALO

as of Jun 30, 2026 · filed Jul 21, 2026 Compact

Position Value

$2,956,570

+$621,489 QoQ

Shares Held

37,774

+4.6% QoQ

Ownership

0.032%

of shares outstanding

% of Portfolio

0.22%

of 13F equity value

Holder Rank

#24

of 154 holders

Holding Since

Mar 2023

14 quarters on record

Voting authority Sole 18% Shared 0% None 82%

Healthcare · as of Jun 30, 2026

CAMPBELL NEWMAN ASSET MANAGEMENT INC holds $7,564,809 across 3 Biotechnology names. HALO ranks #2 (39.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	CPRX	Catalyst Pharmaceuticals, Inc.	96,690	$3,038,966
2	HALO	Halozyme Therapeutics, Inc. This page	37,774	$2,956,570
3	CORT	Corcept Therapeutics Inc	18,048	$1,569,273

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,956,570	37,774	+4.6%	Shares	Sole	2026-07-21
2026-03-31	$2,335,081	36,130	+1.7%	Shares	Sole	2026-04-16
2025-12-31	$2,390,967	35,527	-3.7%	Shares	Sole	2026-01-26
2025-09-30	$2,704,632	36,878	+0.4%	Shares	Sole	2025-10-23
2025-06-30	$1,910,434	36,725	+7.1%	Shares	Sole	2025-07-17
2025-03-31	$2,187,789	34,286	-0.3%	Shares	Sole	2025-04-16
2024-12-31	$1,643,373	34,373	-0.5%	Shares	Sole	2025-01-14
2024-09-30	$1,978,099	34,558	-1.6%	Shares	Sole	2024-10-15
2024-06-30	$1,839,249	35,127	+0.2%	Shares	Sole	2024-07-18
2024-03-31	$1,425,549	35,043	+4.4%	Shares	Sole	2024-04-16
2023-12-31	$1,240,155	33,554	-1.5%	Shares	Sole	2024-01-24
2023-09-30	$1,301,130	34,061	-1.7%	Shares	Sole	2023-10-19
2023-06-30	$1,250,041	34,656	+2.3%	Shares	Sole	2023-07-24
2023-03-31	$1,294,182	33,888	—	Shares	Sole	2023-04-28
No filing history on record for this holder in this stock.